| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/12/2007 | WO2007041439A2 Centrosomal proteins, nucleic acids and method of use thereof |
| 04/12/2007 | WO2007041360A2 Peptides and calcium regulation in mammalian cells |
| 04/12/2007 | WO2007041317A2 Immunomodulatory compositions and uses therefor |
| 04/12/2007 | WO2007041241A2 Compositions and methods for detecting ligand-receptor interactions |
| 04/12/2007 | WO2007041216A2 Plasmodium liver stage antigens |
| 04/12/2007 | WO2007041087A2 Nucleic acids encoding a functional mammalian purinoreceptor, p2x3, methods of production and use thereof |
| 04/12/2007 | WO2007040550A2 Torc polynucleotides and polypeptides, and methods of use |
| 04/12/2007 | WO2007040546A2 Production of recombinant protein pap 31 for the diagnosis and prevention of bartonella bacilliformis infection |
| 04/12/2007 | WO2007040541A1 Re-engineered uv damage endonuclease, compositions and methods |
| 04/12/2007 | WO2007040212A1 Neuronal differentiation inhibitor peptide and use thereof |
| 04/12/2007 | WO2007040105A1 Method for production of t cell population |
| 04/12/2007 | WO2007039963A1 Brain tumor marker for prediction of prognosis of patient with brain tumor and use thereof |
| 04/12/2007 | WO2007039917A1 A vaccine |
| 04/12/2007 | WO2007039911A1 Agent and compositions comprising the same for inhibiting lipases and/or phospholipases in body fluids, cells and tissues |
| 04/12/2007 | WO2007039903A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/12/2007 | WO2007039788A1 Composition and methods for inhibiting h. pylori adhesion and infection |
| 04/12/2007 | WO2007039761A2 Crystal structure of cd44 and its use |
| 04/12/2007 | WO2007039728A2 AVß6 PEPTIDE LIGANDS AND THEIR USES |
| 04/12/2007 | WO2007039716A1 T cell epitopes from the 5t4 tumor associated antigen and their use in treatment of cancer |
| 04/12/2007 | WO2007039699A2 Proteinaceous substrate for the detection of calpain-3 activity |
| 04/12/2007 | WO2007039606A2 Insulin receptor antagonists and related compositions, uses and methods |
| 04/12/2007 | WO2007039599A1 Novel sea lice vaccine |
| 04/12/2007 | WO2007039552A1 Interleukin-1 conjugates and uses thereof |
| 04/12/2007 | WO2007039475A1 Human coagulation factor vii polypeptides |
| 04/12/2007 | WO2007039458A2 Hiv peptide conjugates and uses thereof |
| 04/12/2007 | WO2007039318A2 Neuropeptide y analogs |
| 04/12/2007 | WO2007039305A1 Pleckstrin-based fusion protein and method for monitoring of enzyme activities by fret |
| 04/12/2007 | WO2007039256A2 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 04/12/2007 | WO2007039255A1 Tumor angiogenesis associated genes and a method for their identification |
| 04/12/2007 | WO2007039189A1 Phosphorylated or non-phosphorylated mpr as diagnostic marker or therapeutic target |
| 04/12/2007 | WO2007039184A2 Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones |
| 04/12/2007 | WO2007039140A1 Glp-1 ( glucagon-like peptide-1 ) fusion polypeptides with increased peptidase resistance |
| 04/12/2007 | WO2007039109A1 Tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi) -anchors for treatment of cancer and skin lesions |
| 04/12/2007 | WO2007039070A2 Polynucleotides of haemophilus parasuis and its use |
| 04/12/2007 | WO2007039069A1 Method for the detection of the removal of viruses to validate filters and filtering processes |
| 04/12/2007 | WO2007039065A1 Low ph aerated products |
| 04/12/2007 | WO2007038943A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | WO2007038942A1 Y4 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | WO2007038870A1 A DAIRY DERIVED COMPOSITION ENRICHED IN TGF-β FOR TREATING INFLAMMATION |
| 04/12/2007 | WO2007038837A1 Silk proteins |
| 04/12/2007 | WO2007038829A1 Method of drug design |
| 04/12/2007 | WO2007022623B1 Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria |
| 04/12/2007 | WO2007014744A3 C-terminal tnf-family ligand (ctl) -prodrug |
| 04/12/2007 | WO2007011845A3 Use of a bacillus meti gene to improve methionine production in microorganisms |
| 04/12/2007 | WO2007008937A8 Adiponectin variants |
| 04/12/2007 | WO2007000672A3 Peptidic antagonists of class iii semaphorins/neuropilins complexes |
| 04/12/2007 | WO2006138219A3 Methods of diagnosis / prognosis of inflammatory conditions |
| 04/12/2007 | WO2006138004A3 Immunogenic compositions for chlamydia trachomatis |
| 04/12/2007 | WO2006133911A3 Hepatitis c virus nucleic acid vaccine |
| 04/12/2007 | WO2006131515A3 Stabilised il-21 compositions |
| 04/12/2007 | WO2006129867A3 ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN |
| 04/12/2007 | WO2006128196A3 Novel substrate for rpn 11 enzymatic activity |
| 04/12/2007 | WO2006127822A3 Scytovirin domain 1 related polypeptides |
| 04/12/2007 | WO2006126029A3 Malaria vaccines |
| 04/12/2007 | WO2006121860A3 Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use |
| 04/12/2007 | WO2006111866A3 Hiv vif mutants |
| 04/12/2007 | WO2006107924A3 Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| 04/12/2007 | WO2006103298A3 Blood coagulation fviii analogues |
| 04/12/2007 | WO2006102901A3 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 04/12/2007 | WO2006102896A3 A process to concentrate ω3-pufa from fish oil by selective hydrolysis using cutinase immobilized on zeolite nay |
| 04/12/2007 | WO2006097110A3 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 04/12/2007 | WO2006090282A3 Recombinant inhibitor proteins of an hk14 protease and use thereof |
| 04/12/2007 | WO2006067124A3 Cc-chemokine antagonists |
| 04/12/2007 | WO2006063792A3 Crystal structure of enzyme and uses thereof |
| 04/12/2007 | WO2005107796A3 Cellular permissivity factor for viruses, and uses thereof |
| 04/12/2007 | WO2005107383A3 Secreted insecticidal protein and gene compositions from bacillus thuringiensis and uses therefor |
| 04/12/2007 | WO2005012498A3 Production of porphyrins |
| 04/12/2007 | WO2004072268A3 Pkhdl1, a homolog of the autosomal recessive kidney disease gene |
| 04/12/2007 | WO2004037985A3 Modulation of g protein coupled receptor activity |
| 04/12/2007 | WO2002086079A3 T1r3 a novel taste receptor |
| 04/12/2007 | US20070083953 Polynucleotides, polypeptides encoded for making transgenic plants with improved tolerances to low or chilling temperatures |
| 04/12/2007 | US20070083945 Nucleic acid molecules and other molecules associated with plants |
| 04/12/2007 | US20070083944 Methods to produce desired proteins in plants |
| 04/12/2007 | US20070083941 Rat TRPM7 polynucleotide and encoded protein |
| 04/12/2007 | US20070083940 Transformed silkworm producing human collagen |
| 04/12/2007 | US20070083038 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 04/12/2007 | US20070083037 Monkey npy y4 receptor and method of evaluating compound |
| 04/12/2007 | US20070083006 Method for preparation of site-specific protein conjugates |
| 04/12/2007 | US20070082866 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 04/12/2007 | US20070082860 Hla-a24-restricted cancer antigen peptides |
| 04/12/2007 | US20070082849 Angiogenic peptides and uses thereof |
| 04/12/2007 | US20070082847 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 04/12/2007 | US20070082846 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/12/2007 | US20070082844 Regulation of food preference using GLP-1 agonists |
| 04/12/2007 | US20070082839 Peptide increasing fusiogenic capacity of a gamete |
| 04/12/2007 | US20070082399 Compositions and method for stable isotope labelling of biological compounds |
| 04/12/2007 | US20070082391 Modified CEA Nucleic Acid and Expression Vectors |
| 04/12/2007 | US20070082383 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 04/12/2007 | US20070082381 Polypeptides of Alicyclobacillus sp. |
| 04/12/2007 | US20070082379 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
| 04/12/2007 | US20070082369 Method for production and use of mite group 1 proteins |
| 04/12/2007 | US20070082365 Protein scaffolds for antibody mimics and other binding proteins |
| 04/12/2007 | US20070082362 Modified soluble t cell receptor |
| 04/12/2007 | US20070082361 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 04/12/2007 | US20070082345 Secretory protein or membrane protein |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082336 Methods for protein labeling based on acyl carrier protein |
| 04/12/2007 | US20070082334 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/12/2007 | US20070082015 Cloning and expression of outer membrane protein C of Salmonella typhi Ty2 and conjugation of the purified insoluble protein to VI-polysaccharide for use as a vaccine for typhoid fever |
| 04/12/2007 | US20070082014 Injectable vaccines against multiple meningococcal serogroups |